Clinical Trials Logo

Clinical Trial Summary

The effect of use of the growth hormone with antagonist protocol on the outcome of the IVF/ICSI cycles in poor responders.


Clinical Trial Description

Two groups of poor responder female patients planned to receive the antagonist IVF/ICSI protocol are randomized to whether or not to add growth hormone to their protocol. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02195947
Study type Interventional
Source Cairo University
Contact
Status Completed
Phase Phase 4
Start date July 2014
Completion date July 2015

See also
  Status Clinical Trial Phase
Completed NCT01915186 - Use of Dehydroepiandrosterone (DHEA) in Women With Normal and Poor Ovarian Reserve Undergoing IVF N/A
Withdrawn NCT02209168 - Differences in Ovarian Reserve Markers and Vitamin D Between Infertile Indian, Arabian and Caucasian Population
Completed NCT02341365 - Vitamin D Influence on Oocyte Donation N/A
Completed NCT02185326 - Microflare Protocol in Poor Responders Phase 4
Completed NCT01897324 - IVF/ICSI Protocols in Poor Responders With Growth Hormone Phase 4
Recruiting NCT02294500 - Cohort Study to Evaluate Ovarian Function N/A
Recruiting NCT01662466 - Effect of Testosterone Treatment on Embryo Quality Phase 1/Phase 2
Enrolling by invitation NCT02179255 - Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF Phase 1/Phase 2